Pharmaceutical

Canary Speech Appoints Dr. Kang Hsu, Jr. as Chief Medical Officer to Lead Clinical Strategy and Expand Voice Biomarker Adoption

Digital health innovator brings deep clinical informatics and operational leadership to advance Canary Speech's voice-first technology PROVO, Utah, Aug. 12,...

Senderra Specialty Pharmacy Earns Spot on the 2025 Inc. 5000 List of Fastest-Growing Private Companies for Second Consecutive Year

Back-to-back recognition highlights Senderra's continued growth and commitment to excellence and innovation in specialty pharmacy. DALLAS, Aug. 12, 2025 /PRNewswire/...

Arintra Raises $21M Series A to Expand Beyond Autonomous Medical Coding and Build the Future of Healthcare Revenue Assurance

Healthcare organizations are facing increasing financial strain, but current coding solutions are falling shortArintra helps providers secure full, compliant reimbursement...

MIRA Pharmaceuticals’ Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus Ketamine, Gabapentin, or Pregabalin

Manuscript accepted for publication in Frontiers in Pharmacology, "Oral Administration of Ketamir-2, a Novel Ketamine Analog, Attenuates Neuropathic Pain in...

Zomedica’s Fourth Friday at Four Webinar Returns: Spotlight on the VETIGEL(R) Hemostatic Product – The Future of Rapid Bleeding Control in Veterinary Medicine

Revolutionary Plant-Based Technology Gains Momentum as a Game-Changer in Wound Management ANN ARBOR, MI / ACCESS Newswire / August 12,...

error: Content is protected !!